Results 1 to 10 of about 849,257 (329)
Nursing, 2012 Kirandeep Kaur, Shivani Juneja, Sandeep KaushalDepartment of Pharmacology, Dayanand Medical College and Hospital, Ludhiana, Punjab, IndiaWith reference to the article published under the title "Pharmacologic agents for smoking cessation: A clinical review", we would like to add some information related to smoking cessation ...
Kaur, Kirandeep, Juneja,, Kaushal,
doaj +7 more sources
BMJ, 2008 A 52 year old man with asthma, hyperlipidaemia, and a family history of early onset heart disease comes to see you because of increased wheezing and dyspnoea. He has smoked a pack per day for 36 years. He tried quitting “cold turkey” but felt irritable and couldn’t concentrate; he tried nicotine gum but it didn’t work.
Rigotti Nancy A +2 more
openaire +6 more sources
Chest, 2000 Cigarette smoking is a major preventable cause of morbidity and mortality. It is the major risk factor for chronic obstructive pulmonary disease in the developed world. Smoking is a chronic relapsing disease. Optimal treatment includes nonpharmacologic support, together with pharmacotherapy. All clinicians should be comfortable with the use of nicotine
S I, Rennard, D M, Daughton
openaire +5 more sources
Mindfulness for smoking cessation [PDF]
Cochrane Database of Systematic Reviews, 2020 Mindfulness-based smoking cessation interventions may aid smoking cessation by teaching individuals to pay attention to, and work mindfully with, negative affective states, cravings, and other symptoms of nicotine withdrawal. Types of mindfulness-based interventions include mindfulness training, which involves training in meditation; acceptance and ...
Jackson, S +5 more
openaire +5 more sources
Lobeline for smoking cessation [PDF]
Cochrane Database of Systematic Reviews, 1997 Lobeline is a partial nicotine agonist, which has been used in a variety of commercially available preparations to help stop smoking.The objective of this review was to assess the effects of lobeline on long term smoking cessation.We searched the Cochrane Tobacco Addiction Group trials register (most recent search December 2011).Randomized trials ...
Stead, L, Hughes, JR
openaire +7 more sources
Vascular Medicine, 2016 This issue provides a clinical overview of smoking cessation, focusing on health consequences of smoking, prevention of smoking-related disease, treatment, and practice improvement. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including MKSAP (Medical Knowledge ...
Elizabeth V, Ratchford, Natalie S, Evans
openaire +5 more sources
Aversive smoking for smoking cessation [PDF]
Cochrane Database of Systematic Reviews, 1997 Aversion therapy pairs the pleasurable stimulus of smoking a cigarette with some unpleasant stimulus. The objective is to extinguish the urge to smoke.This review has two aims. First, to determine the efficacy of rapid smoking and other aversive methods in helping smokers stop smoking.
Peter Hajek, Lindsay F Stead
openaire +4 more sources
Economic evaluation of smoking cessation in Ontario's regional cancer programs. [PDF]
, 2018 Quitting smoking after a diagnosis of cancer results in greater response to treatment and decreased risk of disease recurrence and second primary cancers.
Cameron, Erin +10 more
core +1 more source
How important are parents and partners for smoking cessation in adulthood? An event history analysis [PDF]
, 2003 Background. The aim of this study is to assess the effect of parental and partner’s education and smoking behavior on an individual’s chance of smoking cessation over the life course. Methods.
Graaf, Nan Dirk de, +2 more
core +3 more sources
Acute reduction in secretory immunoglobulin A following smoking cessation [PDF]
, 2004 Smokers report an increase in upper respiratory infections in the early phase of stopping smoking. One possible cause is a depletion in secretory immunoglobulin A (S-IgA) which has been observed in one study.
Clow, A +6 more
core +1 more source